Buprenorphine Extended-Release Injection and Novo-Clavamoxin 125
Determining the interaction of Buprenorphine Extended-Release Injection and Novo-Clavamoxin 125 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: amoxicillin / clavulanate
Brand name: Augmentin, Augmentin ES-600, Augmentin XR
Synonyms: Amoxicillin and Clavulanate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Novo-Clavamoxin 250
- Buprenorphine Extended-Release Injection-Novo-Furan Suspension
- Buprenorphine Extended-Release Injection-Novo-Hydrocort Cream Topical application
- Buprenorphine Extended-Release Injection-Novo-Hydrocort Topical application
- Buprenorphine Extended-Release Injection-Novo-Lexin
- Buprenorphine Extended-Release Injection-Novo-Methacin Suppositories
- Novo-Clavamoxin 125-Buprenorphine implant
- Novo-Clavamoxin 125-Buprenorphine Injection
- Novo-Clavamoxin 125-Buprenorphine injection - Buprenex
- Novo-Clavamoxin 125-Buprenorphine injection - Sublocade
- Novo-Clavamoxin 125-Buprenorphine Intradermal
- Novo-Clavamoxin 125-Buprenorphine oral/buccal